Cubist Systematic Strategies, LLC Ironwood Pharmaceuticals Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$8.79 - $11.51 $2.76 Million - $3.62 Million	314,124 Added 197.73%	472,990 $5.41 Million
Q3 2023 Nov 14, 2023	SELL	$8.25 - $11.35 $783,411 - $1.08 Million	-94,959 Reduced 37.41%	158,866 $1.53 Million
Q2 2023 Aug 14, 2023	SELL	$10.1 - $11.6 $3.75 Million - $4.31 Million	-371,548 Reduced 59.41%	253,825 $2.7 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $3.32 Million - $4.02 Million	319,872 Added 104.7%	625,373 $6.58 Million
Q4 2022 Feb 14, 2023	SELL	$9.9 - $12.43 $207,890 - $261,017	-20,999 Reduced 6.43%	305,501 $3.79 Million
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $610,914 - $745,870	60,248 Added 22.63%	326,500 $3.38 Million
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $2.7 Million - $3.11 Million	244,641 Added 1132.02%	266,252 $3.07 Million
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $1.84 Million - $2.23 Million	-173,326 Reduced 88.91%	21,611 $272,000
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $826,706 - $1.06 Million	-76,124 Reduced 28.08%	194,937 $2.27 Million
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $2.29 Million - $2.68 Million	192,427 Added 244.71%	271,061 $3.54 Million
Q2 2021 Aug 16, 2021	BUY	$10.16 - $13.11 $12,242 - $15,797	1,205 Added 1.56%	78,634 $1.01 Million
Q1 2021 May 17, 2021	BUY	$9.04 - $11.86 $61,598 - $80,814	6,814 Added 9.65%	77,429 $866,000
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $109,070 - $147,034	12,052 Added 20.58%	70,615 $804,000
Q3 2020 Nov 16, 2020	SELL	$8.99 - $10.74 $141,026 - $168,478	-15,687 Reduced 21.13%	58,563 $527,000
Q2 2020 Aug 14, 2020	SELL	$9.14 - $11.97 $507,160 - $664,191	-55,488 Reduced 42.77%	74,250 $766,000
Q1 2020 May 15, 2020	SELL	$8.58 - $14.01 $592,268 - $967,096	-69,029 Reduced 34.73%	129,738 $1.31 Million
Q4 2019 Feb 14, 2020	BUY	$8.22 - $14.0 $1.41 Million - $2.39 Million	171,037 Added 616.79%	198,767 $2.65 Million
Q3 2019 Nov 14, 2019	SELL	$8.59 - $10.96 $194,554 - $248,233	-22,649 Reduced 44.96%	27,730 $238,000
Q2 2019 Aug 14, 2019	SELL	$9.8 - $12.89 $1.42 Million - $1.87 Million	-145,103 Reduced 74.23%	50,379 $551,000
Q1 2019 May 15, 2019	BUY	$8.27 - $12.73 $903,423 - $1.39 Million	109,241 Added 126.67%	195,482 $2.65 Million
Q4 2018 Feb 14, 2019	BUY	$7.8 - $16.13 $609,531 - $1.26 Million	78,145 Added 965.23%	86,241 $893,000
Q3 2018 Nov 14, 2018	BUY	$14.31 - $17.65 $115,853 - $142,894	8,096 New	8,096 $149,000
Q1 2018 May 15, 2018	SELL	$11.13 - $13.63 $344,996 - $422,489	-30,997 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.16 - $14.58 $376,923 - $451,936	30,997	30,997 $465,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

Black Rock Inc. New York, NY

22.9M
Shares

$80.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

22M
Shares

$77.8 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$57.9 Million
16.75% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.3M
Shares

$39.8 Million
0.11% of portfolio
State Street Corp Boston, MA

9.92M
Shares

$35 Million
0.0% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account